Maharat Nakhon Ratchasima医院重度子痫前期产妇体重指数与亚治疗血清镁水平的关系

Ratana Boonyongchaisawat, Siraya Kitiyodom
{"title":"Maharat Nakhon Ratchasima医院重度子痫前期产妇体重指数与亚治疗血清镁水平的关系","authors":"Ratana Boonyongchaisawat, Siraya Kitiyodom","doi":"10.14456/TJOG.2016.25","DOIUrl":null,"url":null,"abstract":"Objectives: To evaluate association between the maternal body mass index (BMI) and subtherapeutic serum magnesium level in pregnant women with severe preeclampsia who received magnesium sulfate therapy at Maharat Nakhon Ratchasima Hospital. Study design: Retrospective cross-sectional study. Materials and Methods:  A retrospective study from October 1, 2012 to March 31, 2015 was performed to estimate the effect of maternal BMI on serum magnesium level. And 565(2.99 %) pregnant women had severe preeclampsia and eclampsia diagnosed and received magnesium sulfate therapy at Maharat Nakhon Ratchasima Hospital. Inclusion criteria was pregnant women delivered at gestational age ≥ 24 weeks, not expectant management, received magnesium sulfate in regimen loading dose 4 grams, followed by maintenance dose 1 gram/hour intravenously, and monitored serum magnesium level. Serum magnesium level was monitored initially at 3-4 hours after loading dose, and then monitored every 4 hours during magnesium sulfate infusion. The first serum magnesium level after loading dose was used in the study. Association between maternal BMI and subtherapeutic serum magnesium level (magnesium level 1.1 gm/dL) and thrombocytopenia seem to have higher rate of therapeutic magnesium level significantly (P value < 0.05). Conclusion: Most cases of women with severe preeclampsia at Maharat Nakhon Ratchasima Hospital had subtherapeutic serum magnesium level when magnesium sulfate was administered in regimen loading dose 4 grams, followed by 1 gram per hour intravenously. Overweight and obesity were high risk factor contributing to subtherapeutic of serum magnesium level.","PeriodicalId":36742,"journal":{"name":"Thai Journal of Obstetrics and Gynaecology","volume":"24 1","pages":"145-152"},"PeriodicalIF":0.0000,"publicationDate":"2016-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Association between Maternal Body Mass Index and Sub-therapeutic Serum Magnesium Level in Severe Preeclampsia at Maharat Nakhon Ratchasima Hospital\",\"authors\":\"Ratana Boonyongchaisawat, Siraya Kitiyodom\",\"doi\":\"10.14456/TJOG.2016.25\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objectives: To evaluate association between the maternal body mass index (BMI) and subtherapeutic serum magnesium level in pregnant women with severe preeclampsia who received magnesium sulfate therapy at Maharat Nakhon Ratchasima Hospital. Study design: Retrospective cross-sectional study. Materials and Methods:  A retrospective study from October 1, 2012 to March 31, 2015 was performed to estimate the effect of maternal BMI on serum magnesium level. And 565(2.99 %) pregnant women had severe preeclampsia and eclampsia diagnosed and received magnesium sulfate therapy at Maharat Nakhon Ratchasima Hospital. Inclusion criteria was pregnant women delivered at gestational age ≥ 24 weeks, not expectant management, received magnesium sulfate in regimen loading dose 4 grams, followed by maintenance dose 1 gram/hour intravenously, and monitored serum magnesium level. Serum magnesium level was monitored initially at 3-4 hours after loading dose, and then monitored every 4 hours during magnesium sulfate infusion. The first serum magnesium level after loading dose was used in the study. Association between maternal BMI and subtherapeutic serum magnesium level (magnesium level 1.1 gm/dL) and thrombocytopenia seem to have higher rate of therapeutic magnesium level significantly (P value < 0.05). Conclusion: Most cases of women with severe preeclampsia at Maharat Nakhon Ratchasima Hospital had subtherapeutic serum magnesium level when magnesium sulfate was administered in regimen loading dose 4 grams, followed by 1 gram per hour intravenously. Overweight and obesity were high risk factor contributing to subtherapeutic of serum magnesium level.\",\"PeriodicalId\":36742,\"journal\":{\"name\":\"Thai Journal of Obstetrics and Gynaecology\",\"volume\":\"24 1\",\"pages\":\"145-152\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-09-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Thai Journal of Obstetrics and Gynaecology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14456/TJOG.2016.25\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Thai Journal of Obstetrics and Gynaecology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14456/TJOG.2016.25","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

摘要

目的:评价在Maharat Nakhon Ratchasima医院接受硫酸镁治疗的重度子痫前期孕妇的体重指数(BMI)与亚治疗期血清镁水平的关系。研究设计:回顾性横断面研究。材料与方法:回顾性研究2012年10月1日至2015年3月31日母体BMI对血清镁水平的影响。565名(2.99%)孕妇在玛哈拉特那空叻差玛医院确诊为重度子痫前期和子痫并接受硫酸镁治疗。纳入标准为:胎龄≥24周分娩的孕妇,非准用药,以方案负荷剂量4 g,维持剂量1 g /h静脉注射硫酸镁,并监测血清镁水平。在给药后3-4小时开始监测血清镁水平,在硫酸镁输注期间每4小时监测一次。研究采用负荷剂量后的第一次血清镁水平。孕妇BMI与亚治疗期血清镁水平(镁水平1.1 gm/dL)和血小板减少症的相关性明显高于治疗期血清镁水平(P值< 0.05)。结论:在以方案负荷剂量4 g硫酸镁,随后每小时静脉注射1 g硫酸镁的情况下,大多数在玛哈拉特那叻医院就诊的重度子痫前期妇女血清镁水平均达亚治疗水平。超重和肥胖是导致血清镁亚治疗的高危因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Association between Maternal Body Mass Index and Sub-therapeutic Serum Magnesium Level in Severe Preeclampsia at Maharat Nakhon Ratchasima Hospital
Objectives: To evaluate association between the maternal body mass index (BMI) and subtherapeutic serum magnesium level in pregnant women with severe preeclampsia who received magnesium sulfate therapy at Maharat Nakhon Ratchasima Hospital. Study design: Retrospective cross-sectional study. Materials and Methods:  A retrospective study from October 1, 2012 to March 31, 2015 was performed to estimate the effect of maternal BMI on serum magnesium level. And 565(2.99 %) pregnant women had severe preeclampsia and eclampsia diagnosed and received magnesium sulfate therapy at Maharat Nakhon Ratchasima Hospital. Inclusion criteria was pregnant women delivered at gestational age ≥ 24 weeks, not expectant management, received magnesium sulfate in regimen loading dose 4 grams, followed by maintenance dose 1 gram/hour intravenously, and monitored serum magnesium level. Serum magnesium level was monitored initially at 3-4 hours after loading dose, and then monitored every 4 hours during magnesium sulfate infusion. The first serum magnesium level after loading dose was used in the study. Association between maternal BMI and subtherapeutic serum magnesium level (magnesium level 1.1 gm/dL) and thrombocytopenia seem to have higher rate of therapeutic magnesium level significantly (P value < 0.05). Conclusion: Most cases of women with severe preeclampsia at Maharat Nakhon Ratchasima Hospital had subtherapeutic serum magnesium level when magnesium sulfate was administered in regimen loading dose 4 grams, followed by 1 gram per hour intravenously. Overweight and obesity were high risk factor contributing to subtherapeutic of serum magnesium level.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Thai Journal of Obstetrics and Gynaecology
Thai Journal of Obstetrics and Gynaecology Medicine-Obstetrics and Gynecology
CiteScore
0.40
自引率
0.00%
发文量
3
审稿时长
24 weeks
期刊最新文献
Incidence and Risk Factors of Surgical Site Infections after Abdominal Hysterectomy for Benign Diseases Cannabis (Gan-ja): Relevant Issues in Obstetrics and Gynecology Efficacy of Music Therapy on Immediate Postpartum Episiotomy Pain: A randomized controlled trial Spot Urine Albumin to Creatinine Ratio versus Urine Protein to Creatinine Ratio for the Diagnosis of Proteinuria in Pregnancy Prevalence of Hypothyroidism in Peri-/Post-Menopausal Thai Women
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1